| 注册
首页|期刊导航|世界中医药|养心氏治疗气虚血瘀型冠心病的临床疗效观察

养心氏治疗气虚血瘀型冠心病的临床疗效观察

林欣

世界中医药2017,Vol.12Issue(1):100-103,4.
世界中医药2017,Vol.12Issue(1):100-103,4.DOI:10.3969/j.issn.1673-7202.2017.01.025

养心氏治疗气虚血瘀型冠心病的临床疗效观察

Clinical Effect Observation of YangXinShi in Treatment of Coronary Heart Disease with Qi Deficiency and Blood Stasis Syndrome

林欣1

作者信息

  • 1. 江苏省中医院,南京,210029
  • 折叠

摘要

Abstract

Objective:To evaluate the effects of YangXinShi tablet in treating coronary heart disease with qi deficiency and blood stasis syndrome.Methods:A total of 96 patients who were diagnosed with coronary heart disease complicated with qi deficiency and blood stasis syndrome were randomly divided into YangXinShi group and control group,48 cases in each group.The control group were given western medicine treatment,while the observation group oral administration of YangXinShi tablet on the basis of the treatment in the control group.After three months' treatment,the clinical symptoms of Chinese medicine,angina pectoris,electrocardiogram,hs-CRP,NT-proBNP,Hcy,blood lipids and adverse reactions of all patients were detected.Results:After treatment,1) the total effective rate of improving Chinese medicine symptoms in YangXinShi group (92.8%) was significantly higher than that of control group (75.1%) and the difference was statistically significant (P < 0.05);2) the total effective rate of improving angina pectoris in YangXinShi group (93.75 %) was significantly higher than that of in control group (83.33%),P < 0.05);3)the total effective rate of improving electrocardiogram in treatment group (81.25%) was significantly higher than that of in control group (70.83 %),P < 0.05;4) the hs-CRP,NT-proBNP and Hcy in YangXinShi group were [(1.21 ± 0.27) mg/L,(597 ± 17 1) ng/L and (7.24 ± 0.46) μmol/L] respectively,significantly lower than that of in control group [(1.58 ± 0.37) mg/L,(898 ± 151) ng/ L and (8.93 ± 0.45) μmol/L],P < 0.05;5) the incidence of adverse reactions in YangXinShi group (8.33 %) was significantly lower than that of in control group (14.58%),P < 0.05.Conclusion:YangXinShi tablet combined with western medicine on coronary heart disease with qi deficiency and blood stasis syndrome was better than the conventional western medicine treatment alone.

关键词

养心氏片/冠心病/气虚血瘀/中医症状/心绞痛

Key words

YangXinShi tablet/Coronary heart disease/Qi deficiency and blood stasis/Angina pectoris/Symptoms of Chinese medicine

分类

医药卫生

引用本文复制引用

林欣..养心氏治疗气虚血瘀型冠心病的临床疗效观察[J].世界中医药,2017,12(1):100-103,4.

世界中医药

OACHSSCDCSTPCD

1673-7202

访问量0
|
下载量0
段落导航相关论文